Post-translational modifications of KRAS: from molecular regulation to therapeutic targeting

New class of KRAS inhibitors shows promise at shrinking NF1 nerve tumors

Experimental KRAS vaccine generates immune response against pancreatic cancer in people at high risk - EurekAlert!

KRAS-targeting drugs show promise for rare appendix cancer - EurekAlert!